<mods:mods version="3.3" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-3.xsd" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:mods="http://www.loc.gov/mods/v3"><mods:titleInfo><mods:title>Current relevance of pharmaceutical economy</mods:title></mods:titleInfo><mods:name type="personal"><mods:namePart type="given">Kh. O. Darmanov</mods:namePart><mods:namePart type="family">Kh. O. Darmanov</mods:namePart><mods:role><mods:roleTerm type="text">author</mods:roleTerm></mods:role></mods:name><mods:abstract>Emerging markets represent an exceptional opportunity for the pharmaceutical industry. Although a precise definition is not yet available, economists define emerging markets as developing prosperous countries in which investment is expected to result in higher income despite high risks. Qualifying a market as emerging is not merely based on the economic status of the country, but also on several criteria that render the definition applicable to each country.</mods:abstract><mods:originInfo><mods:dateIssued encoding="iso8601">2024-05-24</mods:dateIssued></mods:originInfo><mods:genre>Maqola</mods:genre></mods:mods>